Ultra-High Speed Analysis of Ibuprofen by Nexera in Accordance with USP 621

Significance of the Topic

High throughput liquid chromatography is critical for pharmaceutical quality control and research. The revision of USP General Chapter 621 allows flexible adjustment of HPLC parameters to accelerate analyses while ensuring system suitability. Rapid determination of ibuprofen and its related substances is essential for timely release of products and effective impurity profiling.

Objectives and Study Overview

This study evaluates an ultra high performance liquid chromatography method for the analysis of ibuprofen, 4-isobutylacetophenone and valerophenone in accordance with USP 621. It compares a conventional Shim-pack VP-ODS column with a core shell Kinetex XB-C18 column and demonstrates how method parameters can be adjusted to achieve high speed separation without revalidation.

Methodology and Instrumentation Used

The analysis was performed on a Nexera UHPLC system equipped with an SPD-20AV UV detector. Two columns were tested:

• Shim-pack VP-ODS 250 mm × 4.6 mm 5 μm
• Kinetex XB-C18 100 mm × 4.6 mm 2.6 μm core shell

Mobile phase consisted of chloroacetic acid water (pH 3.0) and acetonitrile in a 2:3 ratio by volume. Flow rate was set at 2.0 mL/min, column temperature at 30 °C and detection wavelength at 254 nm. Injection volumes were 5 μL for the conventional column and 1 μL for the core shell column.

Main Results and Discussion

Use of the Kinetex core shell column reduced analysis time and solvent consumption by approximately 75 percent compared to the conventional column. System suitability tests met USP criteria for relative retention, resolution, peak symmetry and relative standard deviation. Key performance metrics included resolution above 5 for critical pairs and RSD values below 0.2 percent. In impurity testing, the method reliably quantified 4-isobutylacetophenone at levels below 0.1 percent with high sensitivity and peak resolution.

Benefits and Practical Applications

• Significant reduction in analysis time and solvent usage
• Improved laboratory throughput and cost efficiency
• Compliance with USP 621 without the need for full revalidation
• Enhanced sensitivity for trace impurity detection

Future Trends and Potential Applications

Continued development of core shell and sub two-micron particles is expected to further boost analysis speed and separation efficiency. Integration with automated method scouting and AI based optimization will simplify method transfer under USP guidelines. Green solvent alternatives and microfluidic platforms may also reduce environmental impact and sample requirements.

Conclusion

The combination of a Nexera UHPLC system and a core shell Kinetex XB-C18 column allows ultra-high speed analysis of ibuprofen and its impurities in line with USP 621. This approach achieves robust system suitability, lowers solvent consumption and expedites quality control workflows without extensive revalidation.

Reference

US Pharmacopeia 35 NF 30 General Chapter 621 Official Monograph Ibuprofen